Please login to the form below

David Epstein

This page shows the latest David Epstein news and features for those working in and with pharma, biotech and healthcare.

Novartis splits pharma unit as Epstein exits

Novartis splits pharma unit as Epstein exits. Restructure sees creation of standalone cancer arm Novartis Oncology. ... Novartis has split its pharma business in two, placing all its cancer assets into a separate unit, and announced the departure of

Latest news

As promised, Novartis' Entresto is a 'slow burner'

We cautioned that uptake, particularly in the US, would be very slow at the beginning because access would be blocked," said Novartis' pharma chief David Epstein on the firm's ... Epstein pointed to particularly strong take-up in Germany. Having already
Novartis sets sights on connected inhaler

Head of Novartis Pharmaceuticals David Epstein said: "Novartis supports patients being empowered to make it easier for them to manage their chronic conditions. “
Novartis' Cosentyx cleared for wider use in Europe

D chief David Epstein.
Novartis' Cosentyx off to a flyer in psoriasis

Novartis believes that is because formularies in the US often require patients to try an older drug before Cosentyx and - according to the firm's pharma head David Epstein - that means
Novartis’ Cosentyx on course for new European indications

David Epstein, division head of Novartis, said: “ Novartis is pleased to be so close to bringing this life-changing medicine to people living with ankylosing spondylitis and psoriatic arthritis who are

More from news
Approximately 1 fully matching, plus 43 partially matching documents found.

Latest appointments

David Epstein joins Flagship Pioneering as executive partner

David Epstein joins Flagship Pioneering as executive partner. He most recently served as CEO of Novartis Pharmaceuticals. ... US-based Flagship Pioneering has appointed former Novartis Pharmaceuticals chief executive David Epstein as its executive partner

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Director – Medical Education – Oxford: Negotiable

Senior Account Manager or AD - Medical Communications: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Project Manager, Medical Communications, Oxford: Excellent Salary

Scientific Director: Great salary and bebefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Medical Writer, e-learning/ training, London: Excellent Salary

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Account Manager – Med Comms – London: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Project Manager, Medical Communications, London: Excellent Salary

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Account Manager / Account Director: Great salary and bebefits

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Programme Executive: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Subscribe to our email news alerts

PMHub

Add my company

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...